生命科学资讯

Senate HELP Committee chair pitches proposals for FDA reform

Blood from pediatricians yields potential new medicines for respiratory viruses

Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com

J&J pours $1B into new cell therapy site in Pennsylvania

Michael Hakes' Top Picks: Nu Holdings, Thermo Fisher Scientific & Amazon.com - BNN Bloomberg

Charles River highlights increase in demand as tariff uncertainties fade

Lilly to pay CSL $100M to license monoclonal antibody targeting IL-6

Thermo Fisher boosts connected planning with Oracle Cloud EPM - Oracle

FDA accepts filing for Moderna flu vaccine after swift rethink

Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal

Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug

Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal

T cells store lipids and die in rheumatoid arthritis joints

Thermo Fisher Launches Kit for Sequential Protein, DNA and RNA Extraction - Contract Pharma

Updated: Novartis signs macrocyclic deal with Unnatural Products

Novartis signs macrocyclic deal with Unnatural Products for $100M upfront

Reversal on Moderna's flu application follows atypical path through FDA

FDA accepts BMS protein degrader for review; Disc rare disease drug rejected

An Alzheimer’s startup emerges with $175M in venture backing

Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results